Cite
HARVARD Citation
Shamriz, O. et al. (2020). Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation. Clinical and experimental immunology. pp. 215-227. [Online].